U.S. Virtual Care Market (By Application: Family Medicine, Internal Medicine, Cardiology; By Consultation Mode: Video, Audio, Messaging) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1.Introduction

1.1.Research Objective

1.2.Scope of the Study

1.3.Definition

Chapter 2.Research Methodology

2.1.Research Approach

2.2.Data Sources

2.3.Assumptions & Limitations

Chapter 3.Executive Summary

3.1.Market Snapshot

Chapter 4.Market Variables and Scope

4.1.Introduction

4.2.Market Classification and Scope

4.3.Industry Value Chain Analysis

4.3.1.Raw Material Procurement Analysis

4.3.2.Sales and Distribution Channel Analysis

4.3.3.Downstream Buyer Analysis

Chapter 5.COVID 19 Impact on U.S. Virtual Care Market

5.1.COVID-19 Landscape: U.S. Virtual Care Industry Impact

5.2.COVID 19 - Impact Assessment for the Industry

5.3.COVID 19 Impact: Global Major Government Policy

5.4.Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6.Market Dynamics Analysis and Trends

6.1.Market Dynamics

6.1.1.Market Drivers

6.1.2.Market Restraints

6.1.3.Market Opportunities

6.2.Porter’s Five Forces Analysis

6.2.1.Bargaining power of suppliers

6.2.2.Bargaining power of buyers

6.2.3.Threat of substitute

6.2.4.Threat of new entrants

6.2.5.Degree of competition

Chapter 7.Competitive Landscape

7.1.1.Company Market Share/Positioning Analysis

7.1.2.Key Strategies Adopted by Players

7.1.3.Vendor Landscape

7.1.3.1.List of Suppliers

7.1.3.2.List of Buyers

Chapter 8.Global U.S. Virtual Care Market, By Consultation Mode

8.1.U.S. Virtual Care Market, by Consultation Mode Type, 2022-2030

8.1.1.Video

8.1.1.1.Market Revenue and Forecast (2017-2030)

8.1.2.Audio

8.1.2.1.Market Revenue and Forecast (2017-2030)

8.1.3.Messaging

8.1.3.1.Market Revenue and Forecast (2017-2030)

Chapter 9.Global U.S. Virtual Care Market, By Application

9.1.U.S. Virtual Care Market, by Application, 2022-2030

9.1.1.Family Medicine

9.1.1.1.Market Revenue and Forecast (2017-2030)

9.1.2.Internal Medicine

9.1.2.1.Market Revenue and Forecast (2017-2030)

9.1.3.Cardiology

9.1.3.1.Market Revenue and Forecast (2017-2030)

9.1.4.Pediatrics

9.1.4.1.Market Revenue and Forecast (2017-2030)

9.1.5.Endocrinology

9.1.5.1.Market Revenue and Forecast (2017-2030)

9.1.6.Rheumatology

9.1.6.1.Market Revenue and Forecast (2017-2030)

9.1.7.Pulmonology

9.1.7.1.Market Revenue and Forecast (2017-2030)

9.1.8.Others

9.1.8.1.Market Revenue and Forecast (2017-2030)

Chapter 10.Global U.S. Virtual Care Market, Regional Estimates and Trend Forecast

10.1.North America

10.1.1.Market Revenue and Forecast, by Consultation Mode (2017-2030)

10.1.2.Market Revenue and Forecast, by Application (2017-2030)

10.1.3.U.S.

10.1.3.1.Market Revenue and Forecast, by Consultation Mode (2017-2030)

10.1.3.2.Market Revenue and Forecast, by Application (2017-2030)

10.1.4.Rest of North America

10.1.4.1.Market Revenue and Forecast, by Consultation Mode (2017-2030)

10.1.4.2.Market Revenue and Forecast, by Application (2017-2030)

Chapter 11.Company Profiles

11.1.Teladoc Health, Inc.

11.1.1.Company Overview

11.1.2.Product Offerings

11.1.3.Financial Performance

11.1.4.Recent Initiatives

11.2.American Well Corporation

11.2.1.Company Overview

11.2.2.Product Offerings

11.2.3.Financial Performance

11.2.4.Recent Initiatives

11.3.MDLIVE

11.3.1.Company Overview

11.3.2.Product Offerings

11.3.3.Financial Performance

11.3.4.Recent Initiatives

11.4.Doctor on Demand, Inc.

11.4.1.Company Overview

11.4.2.Product Offerings

11.4.3.Financial Performance

11.4.4.Recent Initiatives

11.5.Virtuwell

11.5.1.Company Overview

11.5.2.Product Offerings

11.5.3.Financial Performance

11.5.4.Recent Initiatives

11.6.CVS health

11.6.1.Company Overview

11.6.2.Product Offerings

11.6.3.Financial Performance

11.6.4.Recent Initiatives

11.7.MeMD

11.7.1.Company Overview

11.7.2.Product Offerings

11.7.3.Financial Performance

11.7.4.Recent Initiatives

11.8.HealthTap, Inc.

11.8.1.Company Overview

11.8.2.Product Offerings

11.8.3.Financial Performance

11.8.4.Recent Initiatives

11.9.iCliniq

11.9.1.Company Overview

11.9.2.Product Offerings

11.9.3.Financial Performance

11.9.4.Recent Initiatives

11.10.Sesame, Inc.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12.Research Methodology

12.1.Primary Research

12.2.Secondary Research

12.3.Assumptions

Chapter 13.Appendix

13.1.About Us

13.2.Glossary of Terms

Report Details

  • Report Code:39241
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:May 2022
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers